Recent federal regulations affecting small businesses
Page 103 of 145 • Last updated April 15, 2026
2165 new federal regulations affecting small businesses have been published in the past 30 days, drawn from the Federal Register, FDA recalls, and USDA notices. Each listing links straight to the official source so you can read the full text and respond if it touches your business.
- Joint Industry Plan; Notice of Filing and Immediate Effectiveness of Amendment to the National Market System Plan Governing the Consolidated Audit Trail Regarding Conversion and Name Change of Nasdaq BX, Inc. to Nasdaq Texas, LLCApril 15, 2026
Joint Industry Plan amends the National Market System Plan's Consolidated Audit Trail rules to reflect Nasdaq BX, Inc.'s conversion and name change to Nasdaq Texas, LLC.
- Self-Regulatory Organizations; Cboe EDGX Exchange, Inc.; Notice of Filing of a Proposed Rule Change To Amend Its Rules To Enable the Exchange To Offer Trading in Equity Securities and Exchange Traded Products 23 Hours per Day, Five Days per WeekApril 15, 2026
Cboe EDGX Exchange proposes extending equity securities and ETF trading hours to 23 hours daily, five days weekly on its exchange platform.
- Teva Pharmaceuticals USA, Inc: Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers and 2 other productsApril 15, 2026
Teva Pharmaceuticals USA recalls 62,136 cartons of Clonidine Transdermal System and two other products due to unapproved raw material use; Class II recall distributed within the U.S.
- Fresenius Kabi USA, LLC: 0.9% Sodium Chloride Injection, USP, (2,250 mg per 250 mL) (9 mg per mL) 250 mL in a 250 mL freeflex bag and 13 other productsApril 15, 2026
Fresenius Kabi USA recalls 0.9% Sodium Chloride Injection and 13 other products nationwide due to lack of sterility assurance, posing potential temporary or reversible health risks.
- GE Healthcare Ireland Limited: GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%) and 1 other productApril 15, 2026
GE Healthcare Ireland Limited recalls 306,810 vials of Omnipaque (iohexol) injection nationwide due to particulate matter that may cause temporary or reversible health problems.
- Self-Regulatory Organizations: Long-Term Stock Exchange, Inc.; Notice of Filing and Immediate Effectiveness of Proposed Rule Change To Amend Exchange Rule 14.602, To Extend the Duration of Certain Term-Limited Complimentary Products and ServicesApril 15, 2026
Long-Term Stock Exchange amends Rule 14.602 to extend the duration of complimentary products and services for listed companies under its term-limited offering structure.
- Self-Regulatory Organizations; NYSE American LLC; Notice of Filing and Immediate Effectiveness of a Proposed Rule Change To Facilitate the Transfer and Trading of Options That Overlie a Reduced Value of the MSCI World Index (1/100), the Full Value of the MSCI ACWI Index and a Reduced Value of the MSCI USA Index (1/100)April 15, 2026
NYSE American proposes rule changes to facilitate trading of options on reduced-value MSCI World Index (1/100), full-value MSCI ACWI Index, and reduced-value MSCI USA Index (1/100) with immediate effectiveness.
- Cipla USA, Inc.: Lanreotide Injection, 120 mg/0.5 mL, Box contains 1 Pre-filled syringe, Single dose only and 1 other productApril 15, 2026
Cipla USA recalls Lanreotide Injection 120 mg/0.5 mL nationwide due to sterility assurance deficiencies at the contract manufacturer's visual inspection procedure.
- Self-Regulatory Organizations; Cboe Exchange, Inc.; Notice of Filing of Amendment No. 3 and Order Granting Accelerated Approval of a Proposed Rule Change, as Modified and Superseded by Amendment No. 3, To Amend Rules 4.13 and 5.1 To Permit Options on the Dow Jones Industrial Average Index To Be P.M.-SettledApril 15, 2026
Cboe Exchange amends rules to permit options on the Dow Jones Industrial Average Index to be settled in the afternoon instead of at market close.
- Tornier, Inc: Tornier HRS Max parts: 1. TORNIER HRS Max Tuberosity Body Lat Coat, Small, Cat. No. ARS1041101 2. TORNIER HRS Max Tuberosity Body No Coat, Small, Cat. No. ARS1041102 3. TORNI...April 15, 2026
Tornier HRS Max tuberosity body components (233 units) are subject to a Class II recall due to incorrect labeling causing incompatibility with the HRS Max system; affected products distributed nationwide across 32 US states.
- Pure Vitamins and Natural Supplements, LLC: Blue Bull Extreme Male Enhancement Supplement, total of 15 pouches per box, Net Wt 15 G each pouch. Dosage: Consume Entire Pouch 30 Minutes before Interc...April 15, 2026
FDA Class I recall of Blue Bull Extreme Male Enhancement Supplement by Pure Vitamins and Natural Supplements, LLC for undeclared sildenafil; distributed in New Jersey.
- Self-Regulatory Organizations; NYSE Arca, Inc.; Notice of Filing and Immediate Effectiveness of a Proposed Rule Change To Facilitate the Transfer and Trading of Options That Overlie a Reduced Value of the MSCI World Index (1/100), the Full Value of the MSCI ACWI Index and a Reduced Value of the MSCI USA Index (1/100)April 15, 2026
NYSE Arca proposes rule changes to facilitate trading of options on reduced-value MSCI World Index (1/100), full-value MSCI ACWI Index, and reduced-value MSCI USA Index (1/100) contracts.
- Combined Notice of Filings #1April 15, 2026 • Impact: none
I'm ready to write single-sentence summaries of US small-business regulations and grant opportunities following your rules, but I don't see a description provided for "Combined Notice of Filings #1." Please provide the description so I can generate …
- Enable Mississippi River Transmission, LLC; Notice of Availability of the Environmental Assessment for the Proposed Ameren-Emrt Big Hollow ProjectApril 15, 2026
The proposed Ameren-EMRT Big Hollow Project environmental assessment is available for public review under the Federal Energy Regulatory Commission process for natural gas transmission infrastructure in Mississippi River transmission zones.
- Agency Information Collection Activities; Proposed Collection; Comment Request; Extension: Form 3-Initial Statement of Beneficial Ownership of SecuritiesApril 15, 2026
Form 3-Initial Statement of Beneficial Ownership of Securities requires officers, directors, and 10% shareholders to disclose equity stakes within two days of taking positions; comments due 60 days from Federal Register publication.